Qoria Ltd. (QOR.AU) rose 51% in early trading in Sydney, after Aura Biosciences Inc. proposed to acquire the companyWallstreetcn·Feb 2 at 11:12 PMAURA-6.67%
The Nasdaq Biotechnology Index rose over 2.4%, outperforming the broader U.S. stock market. Novavax increased by 20.67%, while Ironwood Pharma, Moderna, Vir Biotechnology, BioNTech, Annexon, and Aura Biosciences saw gains between 15.94% and 10.26%. Solid Biosciences rose by 9.61%. In contrast, Zenas Biopharma fell by 6.18%, PepGen dropped by 9.08%, and Legend Biotech decreased by 11.40%Wallstreetcn·Jan 21 at 09:39 PMBBH-0.75%IBBQ-1.81%
The Nasdaq Biotechnology Index closed up nearly 1.4%, closely mirroring the performance of the Dow Jones Industrial Average. Among the constituent stocks, Esperion rose 16.09%, ARS Pharmaceuticals rose 15.50%, Anavex Life Sciences rose 12.34%, Personalis rose 12.31%, Autolus Therapeutics rose 12.10%, and Aura Biosciences rose 11.09%. AC Immune fell 5.84%, LENZ Therapeutics fell 6.51%, and Cullinan Oncology LLC fell 8.82%Wallstreetcn·Nov 25, 2025 at 09:27 PMPSNL-0.06%SPRY-6.70%
